Effects of drugs on aqueous humor dynamics.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000818:Animals; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects; D002415:Cats; D002918:Chymotrypsin / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D004077:Digoxin / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006145:Guanethidine / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007429:Intraocular Pressure / Q000187:drug effects*; D010042:Ouabain / Q000009:adverse effects; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D010293:Pargyline / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011817:Rabbits; D013566:Sympathomimetics / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects; D014665:Vasodilator Agents / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000777:Anesthetics; D002257:Carbonic Anhydrase Inhibitors; D003276:Contraceptives, Oral; D004071:Digitalis Glycosides; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D010042:Ouabain; D004077:Digoxin; D010293:Pargyline; D011433:Propranolol; D002918:Chymotrypsin; D006145:Guanethidine